These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 410692)

  • 1. Potentiation of glibenclamide-induced insulin release by calcium infusion.
    Gero L; Baranyi E; Steczek K; Petrányi G; Tamás G
    Diabetologia; 1977 Aug; 13(4):351-4. PubMed ID: 410692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of glibenclamide therapy on carbohydrate and lipid metabolism and insulin secretion in patients with glucose tolerance disorders : a 5-year study].
    Ratzmann KP; Witt S; Schulz B; Jahr D; Heinke P
    Z Gesamte Inn Med; 1981 Dec; 36(23):913-7. PubMed ID: 6805141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin secretion after oral calcium load.
    Fujita T; Sakagami Y; Tomita T; Okamoto Y; Oku H
    Endocrinol Jpn; 1978 Dec; 25(6):645-8. PubMed ID: 751809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of two sulphonylureas on the dose kinetics of glucose-induced insulin release in normal and diabetic subjects.
    Cerasi E; Efendic S; Thornqvist C; Luft R
    Acta Endocrinol (Copenh); 1979 Jun; 91(2):282-93. PubMed ID: 111449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of glibenclamide treatment on insulin secretion and on insulin binding to erythrocytes in type II diabetes mellitus.
    Araujo LM; Ursich MJ; Pupo AA; Fukui RT
    Braz J Med Biol Res; 1988; 21(1):35-42. PubMed ID: 3140992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation by previous nutrients of glibenclamide-induced insulin release in man. An effect which is counteracted by meal-induced retardation of drug absorption.
    Grill V; Efendić S; Regitz G
    Scand J Clin Lab Invest; 1986 Oct; 46(6):527-32. PubMed ID: 3095909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
    Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
    Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved effect of glibenclamide on administration before breakfast.
    Sartor G; Lundquist I; Melander A; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1982; 21(5):403-8. PubMed ID: 6804245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of glibenclamide treatment on the insulin and glucagon responses to oral glucose and galactose in maturity onset diabetics.
    Hayes JR; Callaghan S; Grant AP
    Diabete Metab; 1979 Sep; 5(3):207-11. PubMed ID: 115730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonylureas in insulin-dependent (type I) diabetes: evidence for an extrapancreatic effect in vivo.
    Pernet A; Trimble ER; Kuntschen F; Assal JP; Hahn C; Renold AE
    J Clin Endocrinol Metab; 1985 Aug; 61(2):247-51. PubMed ID: 3924948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of PGE1 on the liberation of insulin induced by glibenclamide].
    Villar A; D'Ocón MP; Anselmi E
    Rev Esp Fisiol; 1985 Dec; 41(4):451-5. PubMed ID: 3938043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment.
    Owens DR; Biggs PI; Shetty KJ; Wragg KG
    Diabete Metab; 1980 Sep; 6(3):219-24. PubMed ID: 6777211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute changes in serum calcium on glucose tolerance, blood glucose, IRI and cortisol levels.
    Gerö L; Szalay F; Steczek K; Tamás G
    Horm Metab Res; 1976 Mar; 8(2):151-2. PubMed ID: 1261967
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of oral verapamil on glibenclamide stimulated insulin secretion.
    Semple CG; Omile C; Buchanan KD; Beastall GH; Paterson KR
    Br J Clin Pharmacol; 1986 Aug; 22(2):187-90. PubMed ID: 3092851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
    Gudat U; Bungert S; Kemmer F; Heinemann L
    Diabet Med; 1998 Mar; 15(3):194-8. PubMed ID: 9545119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of long-term glibenclamide treatment on glucose tolerance, insulin secretion and serum lipids in subjects with impaired glucose tolerance.
    Ratzmann KP; Witt S; Schulz B
    Diabete Metab; 1983; 9(2):87-93. PubMed ID: 6413265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in calcium dependency of insulin, glucagon and somatostatin secretion in response to glibenclamide in perfused rat pancreas.
    Efendić S; Grill V; Nylén A; Ostensson CG
    Diabetologia; 1982 Jun; 22(6):475-9. PubMed ID: 6125449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.
    Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
    Diabetologia; 1980 Jan; 18(1):17-22. PubMed ID: 6767639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glibenclamide stimulates and glucose inhibits glucagon release induced by calcium deprivation.
    Grill V; Nylén A; Ostenson CG; Efendić S
    Diabetes; 1984 Jun; 33(6):505-9. PubMed ID: 6144608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.